TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC-Reference-Cited by-同舟云学术

TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC

Published:2023-12-20 Issue: Volume: Page:
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Yu Jingtian,Li Mingxing,Ju Lingao^ORCID,Zhou Fenfang,Wang Yejinpeng^ORCID,Zhang Yi^ORCID,Zhang Renjie,Du Wenzhi,Huang Ruoyu,Qian Kaiyu^ORCID,Wang Gang,Xiao Yu^ORCID,Wang Xinghuan^ORCID

Funder

Research Fund of Zhongnan Hospital of Wuhan University

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-023-02922-0.pdf

Reference44 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Prim. 2017;3:17022.

3. van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287–304.

4. Lee SY, Lee SY, Choi Y. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. J Exp Med. 1997;185:1275–85.

5. Cuella-Martin R, Hayward SB, Fan X, Chen X, Huang J-W, Taglialatela A, et al. Functional interrogation of DNA damage response variants with base editing screens. Cell. 2021;184:1081–97.